The Proof with Simon Hill cover image

New heart disease test you should order | Thomas Dayspring, Md

The Proof with Simon Hill

00:00

Mechanism and Impact of PCSK9 Inhibitors on LP little A Levels

This chapter explains how PCSK9 inhibitors influence LP little A levels by interacting with LDL receptors and APO-B particles, discussing the benefits of combining high-dose statins with PCSK9 inhibitors. It explores various drugs' effects on reducing ApoB and LP little a concentrations to mitigate heart disease risks, including the mechanisms of PCSK9 inhibitors, CETP inhibitors, and movalalapin.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app